Embed Size (px)
Citation preview
NHS INNOVATION ACCELERATOR PROGRAMME
In partnership with
2 3
FOREWORD
On 7th January, I opened an international call for applications to the NHS Innovation Accelerator programme. I am delighted to now welcome our first cohort of Fellows, and to thank all those people who have given their time and expertise to supporting the selection process and co-design of the programme.
The NIA aims to deliver on the commitments detailed within the Five Year Forward View - giving people more equitable access to high impact innovations by focusing on the conditions and cultural change needed to enable diffusion of innovations that matter to patients at pace and scale.
By supporting our Fellows and their innovations and acting on their learning, the NHS Innovation Accelerator Programme will build on the UK’s enviable history of discovery and innovation by embracing healthcare from around the world to improve patient care while reducing costs and providing better value for the taxpayer.
I very much look forward to hearing about and learning from the Fellows’ progress during the months ahead, and to working with partners to improve our ability to adopt and diffuse for patient and system benefit.
Professor Sir Bruce KeoghMedical Director, NHS England
FOREWORD
On average it can take 17 years for a great idea to scale within the health service so that it is available for all patients and clinicians who want to use or benefit from it. There is no silver bullet when it comes to getting innovation into practice, but the NHS Innovation Accelerator programme gives healthcare a fantastic opportunity to address historic barriers and develop future strategies for diffusion that are planned from the outset with patients and local communities, supported by national and international learning and expertise.
In partnership with the Academic Health Science Networks across the country and with the support of over 60 assessors and interviewers, we have selected 17 highly impressive healthcare pioneers, dedicated to speeding up the process of adoption and helping larger numbers of patients sooner.
We are very excited to be working with the Fellows throughout the coming year, to learn at an individual and system level from their experiences, and to help them in their quest to make things better for patients today and for future generations.
Professor Sir David Fish Dr Jennifer Dixon Managing Director, UCLPartners Chief Executive, The Health Foundation
4 5
UCLPartners and the Health Foundation co-host the NIA in collaboration with Academic Health Science Networks (AHSNs) across the country and in partnership with NHS England.
The aim of the NIA is to deliver on the commitment detailed within the Five Year Forward View - creating the conditions and cultural change necessary for proven innovations to be adopted faster and more systematically through the NHS, and to deliver examples into practice for demonstrable patient and population benefit.
A call for applications from prospective NHS Innovation Accelerator Fellows was launched by Professor Sir Bruce Keogh, Medical Director NHS England on 7th January 2015. Following a rigorous, multi-stage selection process, the first cohort of 17 Fellows was appointed on the basis of having a set of values and passion for taking a high impact innovation to benefit more people and a wider population, and a
Fellows can each access a bursary of up to £50k. This will be allocated on a quarterly basis in response to their Sprint Plans. Eligible spend for the bursary includes: enabling/enhancing personal learning, enabling system engagement, innovation development, and information/analysis.
BURSARY
NIA Fellows will come together through launch events in July and then once a quarter. At these events, Fellows will take stock, share progress, collectively problem-solve, access practical frameworks/tools and expert challenge. Further opportunities to learn will be created in response to defined needs.
LEARNING PROGRAMME
Fellows will - through a dynamic matching process - have access to a range of seasoned healthcare innovators. The nature of mentoring will vary for each Fellow - some having a single mentor for 12 months, others accessing a range of mentors for specific one-off advice/support.
MENTOR
Each Fellow will have a coach who develops an in-depth understanding of their innovation, ambition and learning needs. They will offer the equivalent of around 12 days support over the initial 12 months through face-to-face, email and phone contact.
COACH
Each Fellow brings to the programme a breadth of skills and knowledge. Fellows will share resources and problem-solve together at planned networking events and by creating further opportunities to work together on shared goals as diffusers.
NIA PEER COMMUNITY
Fellows will develop a 12 month Action Plan detailing their scaling goals and milestones. Fellows will also develop a more detailed 12 week Sprint Plan covering their activities, hypotheses they wish to test and their support needs.
ACTION PLANACTION
PLAN
COACH
MENTOR
NIA PEER COMMUNITY
LEARNING PROGRAMME
BURSARY
willingness to generate system-wide learnings through sharing their experiences of diffusing innovations.
The Fellows will be supported by a learning programme to take their innovations to a larger number of patients at greater pace.
The learning element of the NIA programme has been co–designed with patient networks, Fellows, AHSNs and other partners around an agreed set of principles to ensure it is agile and adaptive, builds from existing national and international infrastructure (rather than reinventing the wheel), is collaborative, and enables the Fellows to test hypotheses around diffusing innovations within the NHS. Technical support for the co-design of the learning programme has been provided by the Innovation Unit www.innovationunit.org
The Fellows will receive support through a variety of mechanisms summarised below:
ABOUT THE NHS INNOVATION ACCELERATOR PROGRAMME
6 7
MEET THE FELLOWS
The 17 Fellows bring to the programme a breadth of expertise and a range of innovations - apps, IP platforms, devices, education, diagnostic pathways, research processes, models of care - applicable to different care settings, seeking to improve both mental and/or physical health.
IT PLATFORM
MODEL OF CARE
SMARTPHONE APP
DEVICE
PATHWAY
WORKFORCE
PROCESS
ANDREA HAWORTH
Andrea has over 20 years’ experience as a state registered clinical scientist in NHS genetic diagnostic laboratories. Andrea’s innovation, SAPIENTIA™, is a genome analytics software enabling healthcare professionals to interrogate the human genome for pathogenic mutations likely to be the cause of a patient’s inherited disease.
This technology, developed from the Deciphering Developmental Disorders (DDD) translational research study, is particularly relevant for rare diseases, 75% of which have a genetic cause that manifests during childhood. On average it takes over five years for patients to receive a diagnosis; by utilising genome and clinical data, SAPIENTIA™ facilitates the rapid identification and interpretation of disease causing variants resulting in a speedier diagnosis and better clinical decision support for patients with rare genetic disease.
Andrea is Head of Clinical Services, Congenica, a company founded on the world-leading DDD genomic technology pioneered at the Wellcome Trust Sanger Institute and the Department of Health.
Contact: [email protected]
IT PLATFORM
8 9
ANNA MOORE
Anna is a Specialist Registrar in Psychiatry at Cambridge, and Implementation Lead for the i-Thrive partnership, involving the Anna Freud Centre, the Tavistock & Portman NHS Foundation Trust, the Dartmouth Centre for Health Care Delivery Science (US) and UCLPartners. She is also an Implementation Fellow at the Anna Freud Centre.
Anna is diffusing i-Thrive, a combinatorial innovation bringing together a new model of care for child and adolescent mental health, Thrive (Wolpert et al), with two validated tools supporting shared decision making, CollaboRATE and Option Grids® (Elwyn, G. et al).
Anna is excited at the prospect of NIA support and the opportunity to learn from colleagues. She aims to implement i-Thrive effectively in a range of local health economies, developing approaches for application to other whole-system transformations.
Anna brings frontline healthcare experience as a trainee psychiatrist and her academic work, including neuroscience research at Harvard University and a PhD, which she is undertaking at UCL on delivering high quality, efficient health care.
Contact: [email protected]
MODEL OF CARE
ANNE BRUINVELS
Anne joins the NIA from the Netherlands where she is founder of PxHealthcare. Anne has devoted much of her international career to the development of more effective, personalised drug treatments and diagnostic tools.
Through Anne’s innovation, OWise, patients record in real time the experiences they have as they undergo treatment for cancer including side-effects and overall quality of life. Through the application, they then receive information about their conditions and wellbeing as well as giving tips as to topics to discuss with their doctor. For clinicians and researchers, OWise offers a wealth of data as to the value of treatments patients are receiving and can therefore support decision-making about what treatments are offered to patients. Anne aims to ensure OWise is available for breast cancer patients across the UK and in the longer term to extend it to other types of cancer.
Contact: [email protected] www.pxhealthcare.com
SMARTPHONE APP
10 11
BEN UNDERWOOD
Ben is an NHS general dental practitioner working in York and is passionate about ensuring all patients have and maintain good oral health throughout their lives to avoid the need for invasive and sometimes expensive dental treatment.
He has developed Brush DJ - the only evidence-based, free, NHS approved app that motivates an effective self-care oral hygiene routine by playing two minutes of the user’s music - making toothbrushing fun! Ensuring children adopt good oral hygiene from a young age will help prevent a number of dental diseases for a lifetime. Ben’s ambition is to help all children to grow up free from dental decay and the consequent need for possibly distressing treatment under general or local anesthetic. Brush DJ aims to do this by motivating an enjoyable, evidence-based oral hygiene self-care routine that is part of everyday life and is available to all children and young people, anywhere.
Contact: www.BrushDJ.comTwitter: @BrushDJ https://twitter.com/BrushDJ Facebook: Brush DJ http://www.facebook.com/pages/Brush-DJ/245442625526057
SMARTPHONE APP
BERNADETTE PORTER
Bernadette was the first nurse in the NHS to be appointed as a multiple sclerosis nurse consultant in 2003 and was awarded an MBE for her work. She has developed and spearheaded NeuroResponse – a new technology that gives patients with neurological conditions more control over the care they receive.
It includes a telephone triage/advice line staffed by specialist nurses, email advice services for GPs wishing to contact a Consultant Neurologist, and a video clinic linking a specialist’s neurology team with the patient and local clinical team in the patient’s community. Using the expert Nurse telephone Triage service, patients and staff can discuss physical, mental, and social care needs, agree plans and share information. The Expert Nurse can triage the patient - patient anxiety is reduced, confidence increases, and treatment interventions are timely.
During the NIA programme, Bernadette plans to scale up the expert telephone component of NeuroResponse for patients with multiple sclerosis across a number of regions and then adapt it for other neurological conditions.
Contact: [email protected]
MODEL OF CARE
12 13
DHARMESH KAPOOR
Dharmesh’s innovation is called EPISCISSORS-60 which are patented fixed angle scissors that take away human error in estimating episiotomy angles during childbirth. This innovation reduces the risk of complications associated with standard practice episiotomies which can cause obstetric anal sphincter muscle injuries and have a devastating impact on the quality of a new mother’s life.
EPISCISSORS-60 is already being used in 15 UK hospitals and Dharmesh’s ambition for the NIA programme is to accelerate diffusion of the use of EPISCISSORS-60 into UK clinical practice.
Dharmesh is director of Medinvent and Consultant Obstetrician and Gynaecologist at the Royal Bournemouth Hospital, Bournemouth.
Contact: [email protected]
DEVICE
FRANCIS WHITE
Francis is the only UK-based employee of US company AliveCor where he has been EU General Manager since January 2013 and set up the local affiliate, AliveCor Ltd. AliveCor has developed the first mobile heart monitor that allows individuals to detect, monitor and manage heart arrhythmias with automatic analysis. Called the AliveCor® Mobile ECG, the device can capture electrocardiogram (ECG) recordings of the heart anytime, anywhere providing instant feedback.
Francis’ ambition is to transform the diagnostic pathway particularly for sufferers of undiagnosed palpitations and other cardiac symptoms. AliveCor enables patients to take an ECG at home or on-the-go, to know when their ECG is normal or not and instantly know if atrial fibrillation (AF), a leading cause of stroke, is detected in the ECG. Also, to easily and remotely share their ECGs with their doctor, thus moving this diagnostic service out of secondary care hospitals and into the community.
Contact: [email protected]
DEVICE
14 15
LLOYD HUMPHREYS
Lloyd is a clinical psychologist by background. He brings Patients know best to the NIA programme, an innovation that enables patients to hold all their medical information in a single record owned by them.
This single record puts the patient at the centre of their care, empowering their health network and challenging traditional models of care. With the patient able to invite anyone they wish to their profile, they can construct a strong and comprehensive care network best suited to them, made up of diverse clinical teams and friends and family able to support at-home care.
Lloyd’s aspiration is that anybody in the UK will have access to their own healthcare data, be able to share it with whomever they please, and to participate proactively with the record to manage and lead their own care.
Contact: [email protected] www.patientsknowbest.com
IT PLATFORM
MARYANNE MARIYASELVAM
Maryanne is Clinical Research Fellow at the Queen Elizabeth Hospital, Kings Lynn and Addenbrooke’s University Hospital, Cambridge. She is currently undertaking a Doctorate at the University of Cambridge relating to Patient Safety in the NHS and is specifically researching the use of innovation to prevent never events or serious adverse events.
Maryanne’s innovation is the Non-injectable arterial connector (NIC), which improves the safety and care of all patients requiring an arterial line in operating theatres and intensive care. Although rare, when wrong route drug administration occurs, it has the potential to cause serious damage to the vessel and surrounding tissue. The NIC enables conventional arterial line sampling, but eradicates the potential to accidentally administer medication into the arterial line and is a definitive solution to the problem.
11 trusts in the east of England are trialling the adoption of the NIC and Maryanne hopes to implement the innovation nationally through the NIA programme.
Contact: @MMariyaselvam
DEVICE
16 17
MATTHEW JAMESON EVANS
HealthUnlocked is a peer-to-peer social support network for health. It links together patients, carers and health advocates with professional and accredited organisations to share experiences of health conditions, symptoms, treatments, and health services. These are catalogued in an intelligent database which signposts relevant content to people based on their profile. By finding others with similar health backgrounds patients can take on day-to-day health concerns together.
Matthew is an ex-Orthopaedic Registrar and says he is continually excited by the generational opportunity to change the world of health with well-made web technology. His ambition whilst on the NIA Programme is to bring the explosive growth and patient engagement HealthUnlocked has cultivated over the last four years and connect it to where it will add most impact across the NHS.
Contact: [email protected]@drmattje @healthunlocked.www.healthunlocked.com
IT PLATFORM
NEIL GUHA
Neil has co-developed a diagnostic pathway to detect significant but asymptomatic chronic liver disease at a critical stage in which it can either progress or reverse. The pathway combines both the identification of patients at risk of chronic liver diseases and utilises proven diagnostic tests to detect and stratify the risk; thirdly it aims to provide a seamless pathway between primary and secondary care. He aims to show that the pathway can be implemented at other sites across the East Midlands before scaling it nationally.
Neil’s ambition for the programme is to gain a greater understanding of how to implement genuine innovation within the NHS infrastructure in a timely manner.
Neil is a Clinical Associate Professor in Hepatology, University of Nottingham and Consultant Hepatologist, at Nottingham University Hospitals.
Contact: [email protected]
PATHWAY
18 19
PAUL VOLKAERTS
Paul founded Nervecentre Software in 2010 to address the absence of strong clinical collaboration tools in the market. His aim was to improve hospital communication that traditionally leads to significant delays in patient care and can result in huge inefficiencies.
Nervecentre Software provides a whole hospital platform that delivers electronic observations, handover, task management and clinical assessments; and allows governance and escalation management to be added to any hospital process. Paul has a background in technical roles and sales and business development roles for blue chip organisations such as Cisco Systems. Paul applied to become a Fellow because he wants to drive significant patient safety and efficiency benefits across UK hospitals, which is essential in achieving a sustainable NHS – Nervecentre has the potential to do this.
Contact: [email protected]
IT PLATFORM
PENNY NEWMAN
Dr Penny Newman has a background in general practice and public health and is currently Medical Director at Norfolk Community Health and Care, and Associate with Health Education East of England. Penny has pioneered the use of health coaching in the NHS to improve outcomes for people with long-term conditions. She has co-designed and led with colleagues from Health Education East of England, Health Coaching training for clinicians so they can enable people to gain the knowledge, skills and confidence to become more active participants in their care, reach self-identified goals and adopt more healthy behaviours. Health coaching is a person-centred process and widely applicable to all long-term conditions, covering prevention, decision making, self-management and medication compliance. Evaluation shows that health coaching can have a transformative impact on clinicians’ practice and can make their work more fulfilling. It provides clinicians with new mindsets and communication techniques that help patients take control of their condition to improve their health and quality of life. Rolled out nationally, health coaching has the potential not only to improve patient outcomes, but also to reduce costs and address inequalities, as it helps clinicians to support more vulnerable patients.
Contact: [email protected]
WORKFORCE
20 21
PETER HAMES
Peter is CEO and co-founder of Big Health, a company that develops personalised behavioural medicine programmes. Peter’s innovation was developed following his own experience of insomnia and the difficulty he experienced in being able to access evidence-based non-drug help via the NHS. Sleepio is a digital sleep improvement programme (available via web and mobile), clinically proven to help overcome even long-term poor sleep. Over a number of weekly sessions, users are taught proven cognitive and behavioural techniques by a virtual sleep expert to help them get their schedule, thoughts and lifestyle into shape. But the impact goes beyond sleep - Sleepio has helped 65% of patients referred to it via an IAPT service move to recovery from depression and anxiety.
Peter’s long term ambition is for Sleepio to be widely available throughout the NHS as a smart, destigmatised way to help people improve their mental health.
Contact: [email protected]
IT PLATFORM
PETER YOUNG
Peter is a proven innovator having developed ten devices, three of which have been brought to market. His innovation on the NIA programme is the PneuX Pneumonia Prevention System, which is designed to stop ventilator-associated pneumonia (VAP), the leading cause of hospital-acquired mortality in Intensive Care Units. The innovation is a cuffed ventilation tube and an electronic cuff monitoring and inflating device which prevents leakage of bacterial laden oral and stomach contents to the lung – a problem associated with standard tubes.
Peter says his experience has shown that coming up with the idea is not the challenge but scaling a great innovation across the NHS involves many challenges. His ambition for the NIA is to overcome the barriers to diffusion.
Peter is Consultant in Anesthesia and Director of Critical Care at the Queen Elizabeth Hospital, Kings Lynn.
Contact: [email protected]
DEVICE
22 23
PIERS KOTTING
Piers has been working to increase the numbers of patients taking part in dementia research. One of the big difficulties researchers face today is recruiting participants for their studies. At the same time, many people are looking for studies to contribute to and take part in, but do not know where to find out about them.
Join Dementia Research allows people to register their interest in participating in dementia research and be matched to suitable studies. This innovation benefits people affected by dementia, and researchers by increasing the speed and reducing the cost of research. It has the potential to drive evidence-based improvements in prevention, diagnosis and treatment of dementia into practice more quickly - and to be generalised to other conditions.
One of his ambitions through the NIA programme is to recruit 100,000 people to register on Join Dementia Research.
Piers has led the development of Join Dementia Research for the past five years and is based at University College London.
Contact: [email protected]
PROCESS
SIMON BOURNE
Simon has developed myCOPD: an IT patient self-management system for Chronic Obstructive Pulmonary Disease (COPD). This is a web based and iOS application that helps patients manage their condition more effectively. The platform interfaces with a clinician dashboard to monitor and manage their patients remotely at an individual and population level.
The platform can also be used by local health care providers and CCGs to monitor exacerbation burdens in real-time and review potential inequalities in health care to plan support services effectively.
Simon is an innovation and respiratory consultant at Portsmouth Hospital and also founder of company my mhealth which utilises mobile technology to provide patients with sophisticated health support information, and clinicians/organisations with tools to manage their populations more effectively.
Contact: [email protected]://mycopd.mymhealth.comhttps://mymhealth.com
IT PLATFORM
24 25
MEET THE MENTORS
A critical element of the support to individual Fellows and the programme will be via access to mentors experienced in taking innovations to scale. The support provided by mentors will predominantly be in the form of advice, guidance and networking.
PROFESSOR THE LORD KAKKAR
The Right Honourable Professor Lord Kakkar is the Chair of UCLPartners. Lord Kakkar is also Professor of Surgery at UCL, Consultant Surgeon at University College London Hospitals NHS Foundation Trust and Director of the Thrombosis Research Institute. He was created a life peer in March 2010. Lord Kakkar moved into the role of Chair in April 2014 having provided leadership support to the partnership as Chair of Quality since its creation in 2009. He was appointed to the Queen’s Privy Council in December 2014.
Lord Kakkar completed his medical education at King’s College Hospital Medical School, University of London and was made a Fellow of the Royal College of Surgeons of England in 1992.
Lord Kakkar’s research interests include prevention and treatment of venous and arterial thromboembolic disease and cancer associated with thrombosis.
BUSINESS AMBASSADOR FOR HEALTHCARE AND SCIENCES UKTI
26 27
PROFESSOR THE LORD DARZI
Professor Darzi holds the Paul Hamlyn Chair of Surgery at Imperial College London, the Royal Marsden Hospital and the Institute of Cancer Research. He is Director of the Institute of Global Health Innovation at Imperial College London and an Honorary Consultant Surgeon at Imperial College Hospital NHS Trust.
Research led by Professor Darzi is directed towards achieving best surgical practice through innovation in surgery and enhancing patient safety and the quality of healthcare. He has published over 950 peer-reviewed research papers to date. In recognition of his achievements, Professor Darzi has been elected as an Honorary Fellow of the Royal Academy of Engineering, a Fellow of the Academy of Medical Science, a Fellow of the Royal Society and a foreign associate of the Institute of Medicine.
He was knighted for his services in medicine and surgery in 2002. Lord Darzi was appointed and remains a member of Her Majesty’s Most Honourable Privy Council since June 2009.
DIRECTOR OF THE INSTITUTE OF GLOBAL HEALTH INNOVATION, IMPERIAL COLLEGE LONDON
PROFESSOR ANDREW MORRIS
Andrew Morris is Professor of Medicine, Director of the Usher Institute of Population Health Sciences and Informatics and Vice Principal of Data Science at the University of Edinburgh, having taken up position in August 2014. Prior to this Andrew was Dean of Medicine at the University of Dundee.
He is seconded as Chief Scientist at the Scottish government Health Directorate, which supports and promotes high quality research aimed at improving the quality and cost-effectiveness of service offered by NHS Scotland and securing lasting improvements to the health of the people of Scotland.
His research interests span informatics and chronic diseases. He is Director of the Farr Institute in Scotland funded by the MRC and nine other funders and Convenor of the UK Health Informatics Research Team Network, representing a £39m investment in health informatics research.
He has published over 300 original papers, and attracted over £50 million in grant funding. Andrew was the principal investigator of the Wellcome Trust United Kingdom Case Control Collection for Type 2 Diabetes that has recruited 20,000 individuals; of Generation Scotland, a study of the genetic health of 50,000 Scots; and of the Wellcome Trust funded Scottish Health informatics Programme (SHIP).
Andrew is Governor of the Health Foundation, a leading UK charity that supports quality improvement in healthcare. Andrew chairs the informatics board at UCLPartners, London.
CHAIRMAN AND CENTRE DIRECTOR, FARR INSTITUTE @ SCOTLAND
28 29
DR. THOMAS LEE
Dr. Thomas Lee joined Press Ganey as Chief Medical Officer in 2013, bringing more than three decades of experience in healthcare performance improvement as a practicing physician, a leader in provider organisations, research and health policy expert. As CMO, Tom is responsible for developing clinical and operational strategies to help providers across the nation measure and improve the patient experience, with an overarching goal of reducing the suffering of patients as they undergo care, and improving the value of that care.
Tom frequently lectures on the patient experience and strategies for improving the value of healthcare, and has authored more than 260 academic articles and two books, Chaos and Organization in Health Care and Eugene Braunwald and the Rise of Modern Medicine.
CHIEF MEDICAL OFFICER, PRESS GANEY
ADRIAN DOWNING
Adrian is Healthcare Director at an award winning SME, Concentra Analytics Consulting, which helps healthcare organisations to better use information to improve the delivery of services and the quality of care for their patients. He has over 20 years of experience in strategy and product development and commercial roles across multiple industries.
For the last five years he has been advising organisations, from start-ups to multi-nationals, on how information can be used to help deliver their stated strategies. He leads projects relating to regulation, commissioning, public health and clinical services in the NHS, private and local authority sectors. Prior to joining Concentra, Adrian held senior roles at Nuffield Health, A.T. Kearney, and Prudential. He has an MSC from London School of Hygiene and Tropical Medicine.
HEALTHCARE DIRECTOR, CONCENTRA
30 31
PROFESSORDONAL O’DONOGHUE
Professor Donal O’Donoghue is Medical Director of the Greater Manchester Academic Health Science Network. He has been a Consultant Renal Physician at Salford Royal since 1992 where he is also University of Manchester Professor of Renal Medicine. He has extensive experience in policy development and leading large-scale improvement. Donal led the development of the National Service Framework for Renal Services and chairs the board of trustees of the British Kidney Patient Association, the largest kidney charity in the UK.
He was also the National Director for Kidney Care at the Department of Health between 2006 and 2013. During this time he chaired the National Directors Forum, the Vascular Board and the Pandemic Influenza Clinical and Operational group. He is a member of Liverpool Clinical Commissioning Group Governing Body. Donal is a practicing kidney doctor, active researcher and in addition to his commitment to Greater Manchester and Liverpool, he is the Chair of the Greater Manchester, Lancashire and South Cumbria Clinical Senate, which provides clinical advice to commissioners.
MEDICAL DIRECTOR, GREATER MANCHESTER AHSN
DR. ROBERT WINTER
Dr. Robert Winter started working on the Small Business Research Initiative (SBRI) in Cambridge University in 2009 and has been closely associated with its development. Administered by Health Enterprise East on behalf of all fifteen Academic Health Science Networks (AHSN), the SBRI Healthcare programme provides start-up funding and advice to small and medium sized enterprises, promoting the national strategy set out in ‘Innovation, Health, and Wealth’ and in ‘Strategy for UK Life Sciences’. The programme, funded by NHS England, has supported the development of a wide range of new technologies – a number of which are now poised to deliver improved quality and value across the NHS.
Formerly Medical Director of Cambridge University Hospitals and a director of the Cambridge University Health Partners, Robert played a leading role in the establishment of fifteen AHSNs in 2013, defined by their shared mission to accelerate innovations.
A respiratory physician by background, he spent four years as the first National Clinical Director of the Respiratory Programme, completing a number of programmes to improve quality of care. Currently a non-executive director of Health Enterpise East and Vice President of the British Lung Foundation, he was appointed OBE for services to medicine and healthcare in the New Year’s honours, 2009.
SMALL BUSINESS RESEARCH INITIATIVE AND HEALTH ENTERPRISE EAST
32 33
PROFESSOR TONY YOUNG
Tony is a practicing frontline NHS surgeon, Director of Medical Innovation at Anglia Ruskin University, and has founded four Med-Tech start-ups. He has also co-founded the £500m Anglia RuskinMed-Tech Campus, which will become one of the world’s largest health innovation spaces.
In 2014, he was appointed as National Clinical Director for Innovation at NHS England. Here he provides clinical leadership and support in delivering improved health outcomes in England and drives the uptake of proven innovations across the NHS, promotes economic growth through innovation and helps make the NHS the go-to place on the planet for medical innovation.
NATIONAL CLINICAL DIRECTOR FOR INNOVATION
DR. SIR SAM EVERINGTON MMBS, MRCGP, BARRISTER
Dr. Sir Sam Everington has been a GP in Tower Hamlets since 1989, is chair of Tower Hamlet’s CCG, NHS England’s national lead for new models of care and a board member of NHSCC. He is part of the Bromley By Bow GP partnership, with over one hundred projects under its roof supporting the wider determinants of health. He is governor of a local primary school and was one of the founders of THEDOC – Tower Hamlets’ GP out of hours service. Sam is a qualified Barrister and a member of BMA council.
In 1999 he received an OBE for services to inner city primary care, in 2006 the International Award of Excellence in Healthcare, and in 2015 a knighthood for services to primary care. He is Director of Community Health Partnerships (NHS Lift), a Trustee of the Kings Fund and has published a number of papers with Professor Aneez Esmail on discrimination in the NHS.
CHAIR, TOWER HAMLETS CLINICAL COMMISSIONING GROUP
34 35
DR. CAZ SAYER
Camden CCG’s Chair is Dr. Caz Sayer. Caz has worked for nearly two decades as a GP at Adelaide Medical Centre in Belsize Park, and has previously been instrumental in establishing many new local health services such as a local referral management service called ‘CCAS’ and better diabetes clinics for people in Camden.
By her involvement in Haverstock Healthcare Ltd, a provider organisation whose shareholders are GP practices, Caz helped to introduce GP-led Urgent Care Services at the Royal Free and UCLH.
Caz was elected as the Chair of Camden CCG in July 2011 and believes in building better links between health and social care services in the local area. She wants to transform services for older people and those with long-term conditions, better serve Camden children with complex needs and improve the quality of healthcare for people in the area living with long-term mental health problems.
CHAIR, CAMDEN CLINICALCOMMISSIONING GROUP
ELLIOT FORSTER
Dr. Elliot Forster joined Immunocore as Chief Executive in January 2015. He has almost 25 years of experience in the pharmaceuticals and biotechnology industry. Dr. Forster previously served as Chief Executive Officer of Creabilis (from 2010) and prior to that role was Chief Executive Officer of a US biotechnology company, Solace Pharmaceuticals Inc.
His other previous roles include Head of EU Development and Operations for the EU and Asia at Pfizer, where he was responsible for drug development across multiple geographies and brought several drugs to market, and Clinical Research manager at GlaxoSmithKline. Dr. Foster is currently Chairman of the MedCity project that aims to grow a world-leading life sciences cluster in the south east of England. He holds a PhD in neurophysiology from Liverpool University and an MBA from Henley Management College.
CHAIRMAN, MED CITY LTD, CHIEF EXECUTIVE, IMMUNOCORE
36 37
SAMANTHA JONES
Samantha started her NHS career as a paediatric and general nurse and was a national management trainee. Having worked in a variety of operational management roles, and in the national clinical governance support team, she became the Chief Executive of Epsom and St. Helier Hospitals NHS Trust. Following this, Samantha worked in the independent sector before she was appointed Chief Executive of West Hertfordshire Hospitals NHS Trust in February 2013.
In 2014 Samantha was awarded HSJ CEO of the Year and the Trust’s “Onion” was highly commended in the patient safety award. In January 2015 Samantha was appointed by NHS England as Director of New Care Models and will lead the implementation of the new care models outlined in the NHS Five Year Forward View.
DIRECTOR OF NEW MODELS OF CARE AT NHS ENGLAND
PROFESSOR SIR JOHN BURN
Professor Sir John Burn is a senior clinical geneticist and academic, based in Newcastle. He holds the NHS Endowed Chair in Clinical Genetics at Newcastle University, and conceived and helped to bring to fruition the Millennium Landmark Centre for Life in Newcastle.
He is a distinguished academic, clinician, and clinical entrepreneur, as well as founder of two spin out companies in the field of genetic diagnosis. He is Chairman of QuantuMDx Itd, a medical device company developing point of care DNA testing for the developing world. He is also a non-executive director on the board of NHS England.
NON-EXECUTIVE DIRECTOR, NHS ENGLAND
38 39
NOEL GORDON
Noel was appointed as a non-executive director on the board of NHS England in July 2014 and he is also Chair of the Specialised Commissioning Committee. Formerly an economist, Noel spent most of his career in consultancy until his retirement in 2014, including the last sixteen years with Accenture, where he was Global Managing Director of the Banking Industry Place.
Noel has extensive practical experience of driving fundamental innovations in transforming industries, and of big data, analytics and digital technologies. Noel holds a first degree in Economics and International Finance from the University of Warwick and an MBA from the Cranfield School of Management. He is Chairman of the Board of Trustees of UserVoice.org
NON-EXECUTIVE DIRECTOR, NHS ENGLAND
DR. SAMANTHA BARRELL
Dr. Sam Barrell joined Taunton and Somerset NHS Foundation Trust in February 2015 having previously been Chief Clinical Officer at South Devon and Torbay Clinical Commissioning Group (CCG).
Sam Trained at Charing Cross and Westminster Medical School before working as an anaesthetist in large acute trusts in London and the south east and then becoming a GP in 2011.
As well as her role at the CCG, Dr. Barrell continued to be a senior partner at the Compass House medical Centre in South Devon. Before that she was Clinical Director of Commissioning and Transition for Torbay Care Trust where her focus centred on improving health and care services for patients through whole system integration.
Sam is a member of the Institute for Public Policy Research Health Advisory Board and in 2013 was named as one of Health Service Journal’s ‘Top 50 most inspirational women in healthcare’. In 2014 Sam was awarded a CBE in the Queen’s Birthday Honours for her services to clinical commissioning and integrated care.
CHIEF EXECUTIVE,TAUNTON AND SOMERSET NHS FOUNDATION TRUST
40 41
ABOUT THE NHS INNOVATION ACCELERATOR PARTNER ORGANISATIONS
NHS England The programme was initiated by and is delivered in partnership with NHS England. NHS England’s primary aim is to improve health outcomes for people in England. NHS England sets the direction and priorities for the NHS as a whole, allocates funding to England’s GP-led clinical commissioning groups, and directly commissions primary care, specialised services and healthcare services for offenders. For more information visit www.england.nhs.uk
Academic Health Science Networks National learning and expertise is provided to the programme through collaboration with the 15 Academic Health Science Networks (AHSNs) across the country. The two key objectives of the Networks are to improve health and generate economic growth. They do this through connecting academics, NHS, researchers and industry to accelerate the process of innovation and facilitate the adoption and spread of innovative ideas and technologies across large populations. For more information on AHSNs visit www.ahsnnetwork.com
Five of the AHSNs are formal partners to the programme and are providing a contribution towards the cost of the bursaries offered to each of the Fellows.
• EastMidlandsAHSNwww.emahsn.org.uk• ImperialAHSN www.imperialcollegehealthpartners.com• NorthWestCoastAHSNwww.nwcahsn.nhs.uk• YorkshireandHumberAHSNwww.yhahsn.org.uk• UCLPartnerswww.uclpartners.com
The Health Foundation is also providing a financial contribution to the bursaries.
Programme mentors International learning and expertise is being provided to the NHS Innovation Accelerator from Professor Victor Dzau, President of the Institute of Medicine of the National Academy of Sciences and Professor Tan Chorh Chuan, President of the National University of Singapore, and Deputy Chairman of the Agency for Science, Technology & Research, Singapore International. Access to global learning, international examples of excellence, and resources is provided by Innovations in Healthcare (formerly International Partnership for Innovative Healthcare Delivery - IPIHD), a collaboration including the World Economic Forum. For more information visit www.innovationsinhealthcare.org
The Health Foundation The Health Foundation is an independent charity working to improve the quality of healthcare in the UK. The organisation supports people working in healthcare practice and policy to make lasting improvements to health services. It carries out research and in-depth policy analysis, runs improvement programmes to put ideas into practice in the NHS, supports and develops leaders, and shares evidence to encourage wider change. The Health Foundation wants the UK to have a healthcare system of the highest possible quality - safe, effective, person-centred, timely, efficient and equitable. For more information visit www.health.org.uk
UCLPartners UCLPartners is an academic health science partnership. Together, our member organisations form one of the world’s leading centres for medical discovery, healthcare innovation and education. We support people and organisations to translate cutting-edge research and innovation into measurable health and wealth gain for patients and populations. We run capability-building programmes, carry out research, and support leaders and organisations to innovate and improve. We work in partnership - in London, across the UK and globally. Crucially for this programme we will be working closely with other AHSNs across England, either as collaborators or partners to the programme. For more information visit www.uclpartners.com
Further information For further information about the programme please contact Amanda Begley, Director of Innovation and Implementation at UCLPartners and Laura Boyd, NIA Programme Manager at [email protected]
ABOUT THE HOST ORGANISATIONS
42 43
In partnership with
